Syra Health Corp. (SYRA)
| Market Cap | 9.10M +546.6% |
| Revenue (ttm) | 7.64M -5.5% |
| Net Income | -183.09K |
| EPS | -0.02 |
| Shares Out | 17.34M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 49,451 |
| Open | 0.6850 |
| Previous Close | 0.6800 |
| Day's Range | 0.5000 - 0.6999 |
| 52-Week Range | 0.0520 - 0.7300 |
| Beta | 3.41 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 7, 2026 |
About Syra Health
Syra Health Corp., a healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education and training, and healthcare workforce development and staffing in the United States. The company offers Syrenity, a behavioral and mental health application that identifies and prevents the progression of negative factors that can influence individuals’ mental health by offering targeted assignments, education, and monitoring symptoms, as well as providing interventions, such as cognitive beh... [Read more]
Financial Performance
In 2025, Syra Health's revenue was $7.23 million, a decrease of -9.47% compared to the previous year's $7.98 million. Losses were -$896,333, -76.16% less than in 2024.
Financial StatementsNews
Syra Health appoints McMahon as Chief Medical Officer
Syra Health (SYRA) announced the appointment of Dr. Cori McMahon, PsyD, NCCE, as Chief Medical Officer. Dr. McMahon also serves as a licensed psychologist at Cooper University Health Care Published…
Syra Health Appoints Dr. Cori McMahon as Chief Medical Officer to Support its Growth Strategy
CARMEL, Ind., July 7, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through preventi...
Syra Health Proxy statement: Proxy filing
Syra Health filed a proxy statement on June 1, 2026, providing details for shareholder voting and corporate governance matters.
Syra Health Proxy statement: Proxy filing
Syra Health filed a proxy statement on June 1, 2026, providing details for shareholder voting and corporate governance matters.
Syra Health Earnings release: Q1 2026
Syra Health released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
Syra Health Quarterly report: Q1 2026
Syra Health has published its Q1 2026 quarterly earnings report on May 7, 2026.
Syra Health Delivers its First Profitable Quarter in Q1 2026, Expands Margins and Strengthens Financial Position
Syra Health delivered its first-ever profitable quarter in Q1 2026, with net income of approximately $241,000, representing a substantial 151% increase over the year-ago period Q1 2026 EPS grew to $0....
Syra Health To Announce First Quarter 2026 Financial Results
CARMEL, Ind., April 30, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA), ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through preve...
Syra Health Wins Innovation of the Year and BioCrossroads Life Sciences Innovation Award at the 2026 TechPoint Mira Awards
Indiana's highest honors in technology and innovation recognize Syra Health's solutions, transforming behavioral and population health. CARMEL, Ind.
Syra Health and Nora Mental Health Announce Telehealth Partnership to Expand Access to Mental and Behavioral Health Services Across Indiana
Collaboration connects AI-powered digital behavioral health platform, Syrenity, with licensed therapists to deliver seamless, affordable care CARMEL, Ind., April 2, 2026 /PRNewswire/ -- Syra Health Co...
Syra Health Annual report: Q4 2025
Syra Health has published its Q4 2025 annual report on March 12, 2026.
Syra Health Earnings release: Q4 2025
Syra Health released its Q4 2025 earnings on March 12, 2026, summarizing the period's financial results.
Syra Health Posts Strong FY2025 Results with 157% Population Health Growth and 76% Net Loss Reduction: Targets Profitability by Year-End 2026
FY2025 EPS improved to ($0.08) compared to ($0.50) in FY2024 YoY net loss reduced 76% to ($896K) from ($3.8M) in FY2024 Population health revenue grew 157% to $5.3 million versus $2.1 million in FY202...
Syra Health To Announce Fourth Quarter and Full Year 2025 Financial Results
CARMEL, Ind., March 5, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA), ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through preven...
Syra Health Appoints Healthcare Executive and Former U.S. Marine Gregory R. Alexander as Chief Executive Officer to Drive Growth
Proven C-Suite Leader with Track Record of Scaling Healthcare Organizations Joins Syra Health to Accelerate Market Expansion and Industry Impact CARMEL, Ind. , Dec. 18, 2025 /PRNewswire/ -- Syra Healt...
Syra Health Quarterly report: Q3 2025
Syra Health has published its Q3 2025 quarterly earnings report on November 12, 2025.
Syra Health Earnings release: Q3 2025
Syra Health released its Q3 2025 earnings on November 12, 2025, summarizing the period's financial results.
Syra Health Announces Third Quarter Financial Results: Margins, Profitability Metrics Improve
Q3 2025 Revenue of $1.7 Million Revenue driven by 96% year-over-year growth in the Population Health segment Gross margin improved 300 basis points to 33% in Q3 2025 from 30% in Q3 2024 Net loss decre...
Syra Health To Announce Third Quarter 2025 Financial Results
CARMEL, Ind. , Nov. 5, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA), ("Syra Health" or the "Company"), a healthcare solutions company powering better health outcomes through innovative service...
Syra Health Proxy statement: Proxy Filing
Syra Health filed a proxy statement on September 19, 2025, providing details for shareholder voting and corporate governance matters.
Syra Health Proxy statement: Proxy Filing
Syra Health filed a proxy statement on September 19, 2025, providing details for shareholder voting and corporate governance matters.
Syra Health Proxy statement: Proxy Filing
Syra Health filed a proxy statement on September 9, 2025, providing details for shareholder voting and corporate governance matters.
Syra Health Quarterly report: Q2 2025
Syra Health has published its Q2 2025 quarterly earnings report on August 12, 2025.
Syra Health Earnings release: Q2 2025
Syra Health released its Q2 2025 earnings on August 12, 2025, summarizing the period's financial results.
Syra Health Announces Second Quarter Financial Results, Advancing Toward Profitability on Margin Gains and Cost Reductions
- Revenue of $1.9 Million consistent with the year-ago period - Revenue led by Population Health's growth up 197% compared to Q2 2024 - Gross Margin increases to 38.7%, up 2,090 basi...